Markets:

Overview

News

Currencies

International

Treasuries

Aldeyra Therapeutics, Inc. - Common Stock (NQ:ALDX)

0.6855 -0.0146 (-2.09%)

Delayed Quote Updated: 2:18 PM EDT, Oct 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aldeyra Therapeutics, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 28, 2021

Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

Why Aldeyra Therapeutics's Stock is Up During Today's Session ↗

April 27, 2021

Aldeyra Therapeutics's Stock Price And Volume Action Aldeyra Therapeutics (NASDAQ:

Via Benzinga

25 Stocks Moving in Wednesday's Pre-Market Session ↗

April 28, 2021

Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today....

Via Benzinga

Aldeyra Seeks To Raise $125M Via Equity To Support Reproxalap US Application ↗

April 28, 2021

Aldeyra Therapeutics Inc (NASDAQ: ALDX) intends to sell $125 million shares of its common stock in an underwritten public offering. Underwriters will...

Via Benzinga

Aldeyra Therapeutics, Inc. Announces Proposed $125 Million Public Offering of Common Stock

April 27, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

52 Biggest Movers From Yesterday ↗

April 28, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (...

Via Benzinga

Mid-Afternoon Market Update: TrueBlue Rises Following Q1 Earnings; RealNetworks Shares Slide ↗

April 27, 2021

Toward the end of trading Tuesday, the Dow traded down 0.02% to 33,975.58 while the NASDAQ fell 0.34% to 14,090.03. The S&P also fell, dropping 0.05% to 4,185.36. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 27, 2021

Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 1%; PQ Group Shares Plummet ↗

April 27, 2021

Midway through trading Tuesday, the Dow traded down 0.08% to 33,955.78 while the NASDAQ fell 0.30% to 14,096.16. The S&P also fell, dropping 0.09% to 4,183.81. The U.S. has...

Via Benzinga

Topics Stocks

Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today ↗

April 27, 2021

Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 27, 2021

Gainers RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1...

Via Benzinga

Why Aldeyra Therapeutics Stock Is Soaring Today ↗

April 27, 2021

The company reported great clinical results for its lead pipeline candidate.

Via The Motley Fool

Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Apr. 27, 2021: UPS, ALDX, FISV, PFPT, GOOG ↗

April 27, 2021

Today's 5 Stock Ideas: United Postal Service (UPS) - Shares were up roughly 8% Tuesday morning. The company reported better-than-expected Q1 EPS and sales results...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 27, 2021

Gainers Aldeyra Therapeutics (NASDAQ:ALDX) stock moved upwards by 25.29% to $13.92 during Tuesday's pre-market session. The company's market cap stands at $661.8...

Via Benzinga

Aldeyra Therapeutics Stock Is Trading Higher On Acing Allergic Conjunctivitis Study With Reproxalap ↗

April 27, 2021

Aldeyra Therapeutics Inc (NASDAQ: ALDX) has announced positive top-line results from the Phase 3 INVIGORATE trial evaluating 0.25% reproxalap, in...

Via Benzinga

24 Stocks Moving in Tuesday's Pre-Market Session ↗

April 27, 2021

Gainers RiceBran Technologies (NASDAQ: RIBT) shares rose 29.1% to $1.20 in pre-market trading. RiceBran Technologies is scheduled to host a conference call on April 28th to...

Via Benzinga

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

Aldeyra Therapeutics Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic Conjunctivitis

April 27, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 INVIGORATE Clinical Trial

April 26, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

44 Biggest Movers From Yesterday ↗

April 23, 2021

Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares...

Via Benzinga

Topics Initial Public Offering

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.